Invest in

Biotech Breakthroughs

8.9%
4.1%
0.3%

Feeling Better About Biotech

The next big cure for a complex, scary disease is unlikely to come from old-school pharma. It’s likely coming from biotech. Scientists, investors, and patients are all banking on the $93 billion biotech industry.[1] It’s outpaced Big Pharma in finding treatments for cancer, AIDS, multiple sclerosis, and other diseases. The FDA approved 43 drugs in 2012, a 20% jump from the previous year.[4] Big Pharma has responded by snapping up promising biotech and smaller pharmaceutical companies, at lofty valuations, with premiums for several public companies in excess of 50%.[2] In fact, 2013 was a big year for the biotech industry, with $29B in M&A deals through the 1st half of 2013.[3] This motif includes only biotech companies with at least two years of cash flow to help screen out companies at greater risk of losing money. See more
8.9%
4.1%
0.3%
Invest in Thematic Portfolios
Create your own customizable basket of up to 30 stocks or ETFs for just $9.95.
Motif Index 1 YR Return
Biotech Breakthroughs Benchmark
With this Motif, you can buy the following basket of stocks for just $9.95:
Weight Segment & Stocks Symbol 1 MO / 1 YR Return
38.9% Cancer 18.2%
21.7% Amgen Inc. AMGN 16.9%
15.0% Celgene Corporation CELG 12.7%
1.4% Seattle Genetics Inc. SGEN 106.6%
0.9% SciClone Pharmaceuticals Inc. SCLN 8.4%
18.4% Other Diseases 3.7%
5.9% Regeneron Pharmaceuticals Inc. REGN 6.1%
5.3% Alexion Pharmaceuticals Inc. ALXN 12.3%
3.8% Vertex Pharmaceuticals Incorporated VRTX 0.6%
2.4% United Therapeutics Corporation UTHR 28.0%
1.1% Acorda Therapeutics Inc. ACOR 29.4%
16.7% Autoimmune Disorders 20.3%
9.4% Biogen Inc. BIIB 9.2%
3.4% Incyte Corporation INCY 61.4%
3.0% BioMarin Pharmaceutical Inc. BMRN 16.4%
0.9% Rigel Pharmaceuticals Inc. RIGL 3.6%
15.8% Infectious Diseases 18.1%
13.7% Gilead Sciences Inc. GILD 19.5%
1.0% Emergent Biosolutions Inc. EBS 16.9%
1.0% Opko Health Inc. OPK 0.3%
10.2% Research & Diagnostics 10.6%
3.9% Illumina Inc. ILMN 3.6%
3.0% Charles River Laboratories International Inc. CRL 20.6%
2.6% Bio-Techne Corp TECH 21.1%
0.7% Meridian Bioscience Inc. VIVO 33.3%

Quotes delayed 15 mins. Currently Feb 19, 2017 1:37:17 PM. Fields are marked with -- when data is unavailable.